LINC00847: A Non-Protein-Coding RNA Molecule as A Potential Drug Target and Biomarker

Target Name: LINC00847

NCBI ID: G729678

LINC00847

Other Name(s): Long intergenic non-protein coding RNA 847, transcript variant 3 | Long intergenic non-protein coding RNA 847, transcript variant 2 | long intergenic non-protein coding RNA 847 | Long intergenic non-protein coding RNA 847, transcript variant 1

LINC00847: A Non-Protein-Coding RNA Molecule as A Potential Drug Target and Biomarker

LINC00847 is a non-protein coding RNA (ncRNA) molecule that has been identified by bioinformatic analysis as containing a potential drug target in its gene. The RNA sequence was identified as LINC00847 and the transcript variant 3.

LINC00847 is a non-coding RNA molecule that is located in the last exon of the LINC0084 gene, which is located on chromosome 19. The LINC0084 gene is a member of the LINC (long non-coding RNA) family, which is known for the production of transcribed RNAs that are involved in various cellular processes.

The LINC0084 gene was first identified in the human genome by bioinformatic analysis in 2012, and has since been found to be involved in the regulation of various cellular processes, including cell adhesion, migration, and the development of cancer.

One of the most promising aspects of LINC00847 is its potential as a drug target. The RNA sequence analysis has identified several potential binding sites on the molecule that could be targeted by small molecules. These sites are located in the region between the initiation and termination codons of the RNA molecule, and are involved in the regulation of various cellular processes.

The potential binding sites on LINC00847 suggest that the molecule could be targeted by small molecules that are able to interact with these sites. This could lead to the development of new drugs that are able to inhibit the activity of LINC00847 and its downstream targets, potentially leading to a treatment for various diseases.

In addition to its potential as a drug target, LINC00847 also has the potential as a biomarker. The RNA sequence analysis has identified that the molecule is expressed in a variety of tissues and cells, including brain, heart, and cancer cells. This suggests that LINC00847 could be used as a biomarker for various diseases, including cancer.

Furthermore, LINC00847 also has the potential as a potential therapeutic target for treating various psychiatric disorders. The RNA sequence analysis has identified that the molecule is involved in the regulation of various cellular processes that are involved in the development of psychiatric disorders.

In conclusion, LINC00847 is a non-protein coding RNA molecule that has been identified as having potential as a drug target and biomarker. The molecule's potential as a drug target is due to its unique RNA sequence and the various cellular processes that it is involved in. The potential use of LINC00847 as a biomarker and its potential as a therapeutic target for psychiatric disorders makes it an exciting area of research.

Protein Name: Long Intergenic Non-protein Coding RNA 847

The "LINC00847 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00847 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets